| Product Code: ETC11505514 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea CAR-T Cell Therapy Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea CAR-T Cell Therapy Market - Industry Life Cycle |
3.4 South Korea CAR-T Cell Therapy Market - Porter's Five Forces |
3.5 South Korea CAR-T Cell Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 South Korea CAR-T Cell Therapy Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.7 South Korea CAR-T Cell Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Korea CAR-T Cell Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 South Korea CAR-T Cell Therapy Market Revenues & Volume Share, By Administration Mode, 2021 & 2031F |
4 South Korea CAR-T Cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased prevalence of cancer in South Korea |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Favorable regulatory environment supporting the adoption of CAR-T cell therapy |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy |
4.3.2 Limited awareness and understanding of CAR-T cell therapy among patients and healthcare providers |
4.3.3 Challenges related to manufacturing and scalability of CAR-T cell therapy |
5 South Korea CAR-T Cell Therapy Market Trends |
6 South Korea CAR-T Cell Therapy Market, By Types |
6.1 South Korea CAR-T Cell Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Autologous CAR-T, 2021 - 2031F |
6.1.4 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Allogeneic CAR-T, 2021 - 2031F |
6.1.5 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Universal CAR-T, 2021 - 2031F |
6.1.6 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Multi-Specific CAR-T, 2021 - 2031F |
6.2 South Korea CAR-T Cell Therapy Market, By Target Antigen |
6.2.1 Overview and Analysis |
6.2.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, By CD19, 2021 - 2031F |
6.2.3 South Korea CAR-T Cell Therapy Market Revenues & Volume, By BCMA, 2021 - 2031F |
6.2.4 South Korea CAR-T Cell Therapy Market Revenues & Volume, By CD22, 2021 - 2031F |
6.2.5 South Korea CAR-T Cell Therapy Market Revenues & Volume, By HER2, 2021 - 2031F |
6.3 South Korea CAR-T Cell Therapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Hematologic Cancers, 2021 - 2031F |
6.3.3 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Solid Tumors, 2021 - 2031F |
6.3.4 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Neuroblastoma, 2021 - 2031F |
6.3.5 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Lymphoma, 2021 - 2031F |
6.4 South Korea CAR-T Cell Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.5 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Biotech Firms, 2021 - 2031F |
6.5 South Korea CAR-T Cell Therapy Market, By Administration Mode |
6.5.1 Overview and Analysis |
6.5.2 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.5.4 South Korea CAR-T Cell Therapy Market Revenues & Volume, By Gene-Modified, 2021 - 2031F |
6.5.5 South Korea CAR-T Cell Therapy Market Revenues & Volume, By CRISPR-Enhanced, 2021 - 2031F |
7 South Korea CAR-T Cell Therapy Market Import-Export Trade Statistics |
7.1 South Korea CAR-T Cell Therapy Market Export to Major Countries |
7.2 South Korea CAR-T Cell Therapy Market Imports from Major Countries |
8 South Korea CAR-T Cell Therapy Market Key Performance Indicators |
8.1 Average time to market approval for new CAR-T cell therapies in South Korea |
8.2 Number of clinical trials and research studies related to CAR-T cell therapy in the country |
8.3 Percentage of healthcare facilities offering CAR-T cell therapy services in South Korea |
9 South Korea CAR-T Cell Therapy Market - Opportunity Assessment |
9.1 South Korea CAR-T Cell Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 South Korea CAR-T Cell Therapy Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.3 South Korea CAR-T Cell Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Korea CAR-T Cell Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 South Korea CAR-T Cell Therapy Market Opportunity Assessment, By Administration Mode, 2021 & 2031F |
10 South Korea CAR-T Cell Therapy Market - Competitive Landscape |
10.1 South Korea CAR-T Cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 South Korea CAR-T Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here